Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk, 630090, Russia.
Biochemistry (Mosc). 2020 Nov;85(11):1350-1361. doi: 10.1134/S0006297920110061.
The increasing prevalence of bacterial pathogens with multiple antibiotic resistance requires development of new approaches to control infections. Phage therapy is one of the most promising approaches. In recent years, research organizations and a number of pharmaceutical companies have intensified investigations aimed at developing bacteriophage-based therapeutics. In the United States and European countries, special centers have been established that experimentally apply phage therapy to treat patients who do not respond to antibiotic therapy. This review describes the features of bacteriophages as therapeutic tools, critically discusses the results of clinical trials of bacteriophage preparations, and assesses the prospects for using phage therapy to treat certain types of infectious diseases.
细菌病原体对抗生素的耐药性日益普遍,这就需要开发新的方法来控制感染。噬菌体疗法就是最有前途的方法之一。近年来,研究机构和一些制药公司加强了研究,旨在开发基于噬菌体的疗法。在美国和欧洲国家,已经建立了专门的中心,实验性地应用噬菌体疗法来治疗对抗生素治疗无反应的患者。本文描述了噬菌体作为治疗工具的特点,批判性地讨论了噬菌体制剂临床试验的结果,并评估了噬菌体疗法治疗某些类型传染病的前景。